Mr. Editor I am writing to highlight the growing concern regarding a severe complication of thrombolytic therapy, intracranial hemorrhage, and the need to identify associated risk factors. Considering the frequency of comorbidities in stroke patients worldwide, it is essential to provide a global perspective on this issue.
No takes yet. Share an insight, caveat, or question.
Junior Ernesto Melo Torres (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: